4-(1-(2-AMINO-5-CHLOROPYRIMIDIN-4-YL)INDOLIN-6-YL)-2-(5-METHYLISOXAZOL-3-YL)BUT-3-YN-2-OL
UNII YP9G9CAK8Z
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(1-(2-amino-5-chloropyrimidin-4-yl)indolin-6-yl)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YP9G9CAK8Z.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H18ClN5O2 YZLVZEPJQXFXFT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(1-(2-amino-5-chloropyrimidin-4-yl)indolin-6-yl)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.